Pharmagreen Biotech Inc. [Rocket]

Overview

Pharmagreen Biotech Inc.

Recent News + Filings (All items)

Date Filed	Type	Description
08/14/2023	10-Q	Quarterly Report for the period ended June 30, 2023
05/19/2023	10-Q	Quarterly Report for the period ended March 31, 2023
05/18/2023	8-K	Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits  Interactive Data
05/12/2023	NT 10-Q	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
02/14/2023	10-Q	Quarterly Report for the period ended December 31, 2022
01/17/2023	10-K	Annual Report for the period ended September 30, 2022
12/28/2022	NT 10-K	Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405:

Revenue Mix by Segment

Financial Summary (All financials)

In millions, except per share items	Sep-30-22	Sep-30-21	Sep-30-20	Sep-30-19	Sep-30-18	Sep-30-17
Revenues	0.0	0.8	0.0	0.0	0.0	0.0
Revenue growth	-100.0%	-2375.0%		-100.0%	70.4%
Cost of goods sold	0.0	0.0	-1.0	0.6	0.0	0.0
Gross profit	0.0	0.8	0.9	-0.6	0.0	0.0
Gross margin		100.0%	-2836.2%		0.0%	0.0%
Selling, general and administrative				0.2
Sales and marketing					0.0
Research and development				0.0	0.0
General and administrative	0.1	0.2	0.3	0.1	0.2	0.2
EBIT	-1.1	-0.7	-0.5	-0.8	-0.9	-0.7
EBIT margin		-98.8%	1465.4%		-5080.5%	-7173.1%
Pre-tax income	-0.9	-4.5	-2.4	-0.8	-1.1	-0.8
Income taxes	0.0	0.0	0.0	0.0	0.0	-0.2
Tax rate	0.0%		0.0%	0.0%	0.0%	21.3%
Earnings from continuing ops	-0.9	-4.5	-2.5	-0.8	-1.1	-0.9
Earnings from discontinued ops						0.2
Net income	-0.9	-4.5	-2.5	-0.8	-1.1	-0.8
Net margin		-602.1%	7503.3%		-6251.9%	-7663.2%

Diluted EPS	$0.00	($0.01)	($0.01)	($0.01)	$0.00	($0.05)
Shares outstanding (diluted)	403.7	326.0	388.4	76.8	293.1	20.6

EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.